IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX)

83 filings reported holding IMUX - IMMUNIC, INC. - Common Stock, $0.0001 par value as of Q1 2025.
IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 40.5M shares of 95.8M outstanding shares and own 42.22% of the company stock.
Largest 10 shareholders include BVF INC/IL (8.9M shares), Soleus Capital Management, L.P. (7.29M shares), Avidity Partners Management LP (4.45M shares), VANGUARD GROUP INC (3.93M shares), Focus Partners Wealth (2.58M shares), Omega Fund Management, LLC (1.79M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.4M shares), Aberdeen Group plc (1.06M shares), GEODE CAPITAL MANAGEMENT, LLC (976K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (950K shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.